Log in to save to my catalogue

Long-term incidence of severe malaria following RTS,S/AS01 vaccination in children and infants in Af...

Long-term incidence of severe malaria following RTS,S/AS01 vaccination in children and infants in Af...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2257706809

Long-term incidence of severe malaria following RTS,S/AS01 vaccination in children and infants in Africa: an open-label 3-year extension study of a phase 3 randomised controlled trial

About this item

Full title

Long-term incidence of severe malaria following RTS,S/AS01 vaccination in children and infants in Africa: an open-label 3-year extension study of a phase 3 randomised controlled trial

Publisher

United States: Elsevier Ltd

Journal title

The Lancet infectious diseases, 2019-08, Vol.19 (8), p.821-832

Language

English

Formats

Publication information

Publisher

United States: Elsevier Ltd

More information

Scope and Contents

Contents

Results from a previous phase 3 study showed efficacy of the RTS,S/AS01 vaccine against severe and clinical malaria in children (in 11 sites in Africa) during a 3–4-year follow-up. We aimed to investigate malaria incidence up to 7 years postvaccination in three of the sites of the initial study.
In the initial phase 3 study, infants aged 6–12 we...

Alternative Titles

Full title

Long-term incidence of severe malaria following RTS,S/AS01 vaccination in children and infants in Africa: an open-label 3-year extension study of a phase 3 randomised controlled trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2257706809

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2257706809

Other Identifiers

ISSN

1473-3099,1474-4457

E-ISSN

1474-4457

DOI

10.1016/S1473-3099(19)30300-7

How to access this item